EGFR and lung carcinoma: Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most common oncogenic driver in solid tumors including lung cancer and was associated with a worse prognosis and resistance to chemotherapy and anti-epidermal growth factor receptor (EGFR) treatment [1,2].